BPC-157

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic peptide consisting of 15 amino acids. It is derived from a naturally occurring protein found in human gastric juice. The “157” designation refers to its position in the parent protein sequence.

First described in the 1990s by Croatian researcher Predrag Sikirić and colleagues, BPC-157 has since become one of the most studied peptides in preclinical research, with hundreds of animal studies exploring its broad cytoprotective effects.

How BPC-157 Works

BPC-157 is thought to exert its effects through multiple mechanisms:

• Angiogenesis stimulation: Promotes the formation of new blood vessels, accelerating tissue repair
• Growth factor upregulation: Increases expression of VEGF (vascular endothelial growth factor) and other growth factors
• Nitric oxide modulation: Influences nitric oxide pathways involved in vascular health
• Tendon fibroblast activation: Stimulates tendon healing cells to proliferate and migrate
• Anti-inflammatory signaling: Modulates inflammatory cytokine cascades

Research Summary

Animal research has investigated BPC-157 across a wide range of applications:

Musculoskeletal Healing

Multiple studies in rodent models have shown accelerated healing of transected tendons, ligament injuries, and muscle tears. A 2011 study in the Journal of Applied Physiology found that BPC-157 significantly improved tendon healing through enhanced collagen production and tenocyte proliferation.

Gastrointestinal Protection

BPC-157 shows strong cytoprotective effects in the GI tract, including protection against NSAID-induced gastric lesions, inflammatory bowel disease models, and esophageal damage.

Neurological Effects

Some animal research suggests neuroprotective and antidepressant-like effects, though this area requires more investigation.

Safety Considerations

• No human clinical trials have been completed
• Animal toxicology studies show no adverse effects at typical research doses
• The peptide is considered stable and can be administered subcutaneously or intranasally in research settings
• Long-term safety in humans is unknown

Medical Disclaimer: BPC-157 is not approved by the FDA for human use. This information is for educational purposes only. Do not use peptides without consulting a licensed healthcare provider.

Legal & Regulatory Status

In the United States, BPC-157 is not FDA-approved and cannot be legally prescribed or sold as a drug. In 2023, the FDA moved BPC-157 to its Category 2 list, prohibiting its use in compounded medications. It remains available for legitimate laboratory research purposes only.

Related Reading

• What Is BPC-157? A Beginner’s Overview — Accessible introduction to BPC-157 and its research context
• BPC-157 and Gut Health: What the Research Actually Shows — Deep dive on the GI evidence: NSAID protection, IBD models, leaky gut, gut-brain axis
• The Science Behind BPC-157 and Injury Recovery — Musculoskeletal and tissue repair evidence
• BPC-157 for Pain Relief: Oral vs. Injectable — Mechanism and route comparison including oral bioavailability data
• FDA Peptide Status 2026: What’s Legal, What’s Not — BPC-157’s Category 2 classification in context
• Peptide Storage and Reconstitution Guide — How to handle research peptides safely